Highlights
About
Noninvasive Diagnosis of Cardiac Disease
BSP - Biological Signal Processing offers products for the noninvasive diagnosis and monitoring of ischemic heart disease. The companys HyperQ line of products, which arebased on patented high-frequency technology, offers solutions for both stress ECG tests and resting ECG tests. The HyperQ Stress offers a significant improvement in the diagnosis of patients suspected of having coronary artery disease. The HyperQ Rest provides a tool to enable emergency department teams to detectacute coronary syndrome. Numerous trials and clinical studies conducted with thousands of patients in Israel, Europe, Asia, and the United Stateshave confirmed the significantly enhanced diagnostic value of the HyperQ technology for the detection of ischemia.
Identity
| Name | BSP - Biological Signal Processing |
|---|---|
| Slug | bsp |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6vo5ALDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, May 2018 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Raoul Wallenberg Street 22, Tel Aviv-Yafo, Israel |
Web & social
| https://www.linkedin.com/company/1628800 | |
| YouTube | https://www.youtube.com/channel/UC-kI6SX1mWAsJByw0Kro-dw |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}